Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 12353202)

1.

Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure.

Bradshaw CS, Brotman RM.

BMC Infect Dis. 2015 Jul 29;15(1):292. doi: 10.1186/s12879-015-1027-4.

2.

Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health.

Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S.

Front Physiol. 2015 Mar 25;6:81. doi: 10.3389/fphys.2015.00081. eCollection 2015. Review.

3.

Biological control of vaginosis to improve reproductive health.

Mastromarino P, Hemalatha R, Barbonetti A, Cinque B, Cifone MG, Tammaro F, Francavilla F.

Indian J Med Res. 2014 Nov;140 Suppl:S91-7.

4.

Anaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisation.

Africa CW, Nel J, Stemmet M.

Int J Environ Res Public Health. 2014 Jul 10;11(7):6979-7000. doi: 10.3390/ijerph110706979. Review.

5.

Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis.

Vodstrcil LA, Hocking JS, Law M, Walker S, Tabrizi SN, Fairley CK, Bradshaw CS.

PLoS One. 2013 Sep 4;8(9):e73055. doi: 10.1371/journal.pone.0073055. eCollection 2013. Review.

6.

Influence of iron status on risk of maternal or neonatal infection and on neonatal mortality with an emphasis on developing countries.

Brabin L, Brabin BJ, Gies S.

Nutr Rev. 2013 Aug;71(8):528-40. doi: 10.1111/nure.12049. Epub 2013 Jun 6.

7.

Safety and efficacy of an intravaginal prebiotic gel in the prevention of recurrent bacterial vaginosis: a randomized double-blind study.

Coste I, Judlin P, Lepargneur JP, Bou-Antoun S.

Obstet Gynecol Int. 2012;2012:147867. doi: 10.1155/2012/147867. Epub 2012 Dec 18.

8.

Vaginal microbiome: rethinking health and disease.

Ma B, Forney LJ, Ravel J.

Annu Rev Microbiol. 2012;66:371-89. doi: 10.1146/annurev-micro-092611-150157. Epub 2012 Jun 28. Review.

9.

Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.

Bradshaw CS, Pirotta M, De Guingand D, Hocking JS, Morton AN, Garland SM, Fehler G, Morrow A, Walker S, Vodstrcil LA, Fairley CK.

PLoS One. 2012;7(4):e34540. doi: 10.1371/journal.pone.0034540. Epub 2012 Apr 3.

10.

Recalcitrance of bacterial vaginosis among herpes-simplex-virus-type-2-seropositive women.

Stoner KA, Reighard SD, Vicetti Miguel RD, Landsittel D, Cosentino LA, Kant JA, Cherpes TL.

J Obstet Gynaecol Res. 2012 Jan;38(1):77-83. doi: 10.1111/j.1447-0756.2011.01697.x. Epub 2011 Dec 5.

11.

Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.

Lamont RF, Nhan-Chang CL, Sobel JD, Workowski K, Conde-Agudelo A, Romero R.

Am J Obstet Gynecol. 2011 Sep;205(3):177-90. doi: 10.1016/j.ajog.2011.03.047. Epub 2011 Apr 2. Review.

12.

The natural history of bacterial vaginosis diagnosed by gram stain among women in Rakai, Uganda.

Thoma ME, Gray RH, Kiwanuka N, Wang MC, Sewankambo N, Wawer MJ.

Sex Transm Dis. 2011 Nov;38(11):1040-5. doi: 10.1097/OLQ.0b013e3182275499.

13.

Antibacterial treatment of bacterial vaginosis: current and emerging therapies.

Menard JP.

Int J Womens Health. 2011;3:295-305. doi: 10.2147/IJWH.S23814. Epub 2011 Aug 23.

14.

Bacterial vaginosis is associated with variation in dietary indices.

Thoma ME, Klebanoff MA, Rovner AJ, Nansel TR, Neggers Y, Andrews WW, Schwebke JR.

J Nutr. 2011 Sep;141(9):1698-704. doi: 10.3945/jn.111.140541. Epub 2011 Jul 6.

15.

In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis?

Togni G, Battini V, Bulgheroni A, Mailland F, Caserini M, Mendling W.

Antimicrob Agents Chemother. 2011 May;55(5):2490-2. doi: 10.1128/AAC.01623-10. Epub 2011 Feb 14.

16.

Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID.

Marrazzo JM, Martin DH, Watts DH, Schulte J, Sobel JD, Hillier SL, Deal C, Fredricks DN.

Sex Transm Dis. 2010 Dec;37(12):732-44. doi: 10.1097/OLQ.0b013e3181fbbc95.

17.

Pharmacokinetics of metronidazole in pregnant patients with bacterial vaginosis.

Wang X, Nanovskaya TN, Zhan Y, Abdel-Rahman SM, Jasek M, Hankins GD, Ahmed MS.

J Matern Fetal Neonatal Med. 2011 Mar;24(3):444-8. doi: 10.3109/14767058.2010.497573. Epub 2010 Jul 7.

18.

Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy.

Mitchell C, Balkus J, Agnew K, Lawler R, Hitti J.

J Womens Health (Larchmt). 2009 Nov;18(11):1817-24. doi: 10.1089/jwh.2009.1378.

19.

Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria.

Mitchell CM, Hitti JE, Agnew KJ, Fredricks DN.

BMC Infect Dis. 2009 Jun 10;9:89. doi: 10.1186/1471-2334-9-89.

20.

The effect of body mass index on therapeutic response to bacterial vaginosis in pregnancy.

Mastrobattista JM, Klebanoff MA, Carey JC, Hauth JC, Macpherson CA, Ernest J, Cotroneo M, Leveno KJ, Wapner R, Varner M, Iams JD, Moawad A, Sibai BM, Miodovnik M, Dombrowski M, O'Sullivan MJ, Vandorsten JP, Langer O; National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Networks.

Am J Perinatol. 2008 Apr;25(4):233-7. doi: 10.1055/s-2008-1066875.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk